Pharma Promotion / United States / Notices & guidance
United States ── Notices & guidance
166 records since 1990, judged by Jev for relevance, jurisdiction, type and importance.
2026 10
- Notices & guidance2026-08-10Pharmaceutical ExecutiveThe Significance of FDA’s First Warning Letter for Inappropriate Use of AI
- Notices & guidance2026-07-30Fierce PharmaViatris runs into FDA roadblock after advertising on-the-go use of cystic fibrosis inhaler
- Notices & guidance2026-07-22Fierce PharmaFDA calls out Sanofi emails for giving 'misleading impression' of Beyfortus use in RSV
- Notices & guidance2026-07-21Medical Marketing and MediaFDA slaps Sanofi, Viatris with Untitled Letters over promotional emails, TV ad
- Notices & guidance2026-07-10Endpoints NewsFDA criticizes Lundbeck for webpages promoting migraine treatment Vyepti
- Notices & guidance2026-07-10Medical Marketing and MediaFDA takes first step toward ‘de facto’ ad ban: What to know - MM+M
- Notices & guidance2026-07-08Medical Marketing and MediaFDA sends Untitled Letter to Lundbeck over Vyepti efficacy claims on webpages
- Notices & guidance2026-07-08Fierce PharmaFDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Notices & guidance2026-07-07Foley HoagFDA Proposes to Eliminate "Adequate Provision" for Broadcast Prescription Drug Advertising
- Notices & guidance2026-04-27JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACYDirect‐to‐Consumer Advertising of Prescription Medications
2025 1
- Notices & guidance2025-12-10Federal Register（Notice）Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers; Guidance for Industry; Availability
2024 2
- Notices & guidance2024-07-09Federal Register（Notice）Addressing Misinformation About Medical Devices and Prescription Drugs: Questions and Answers; Draft Guidance for Industry; Availability; Agency Information Collection Activities; Proposed Collection; Comment Request
- Notices & guidance2024-04-25Federal Register（Notice）Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and Interchangeable Biosimilar Products: Questions and Answers; Revised Draft Guidance for Industry; Availability
2023 8
- Notices & guidance2023-12-21Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Implied Claims in Direct-to-Consumer Prescription Drug Promotion
- Notices & guidance2023-12-21Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Implied Claims in Direct-to-Consumer Prescription Drug Promotion
- Notices & guidance2023-12-18Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising
- Notices & guidance2023-06-28Federal Register（Notice）Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements; Guidance for Industry; Availability
- Notices & guidance2023-04-25Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising
- Notices & guidance2023-04-25Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising
- Notices & guidance2023-03-31Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prescription Drug Advertising
- Notices & guidance2023-03-31Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prescription Drug Advertising
2022 3
- Notices & guidance2022-04-25Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Tradeoff Analysis of Prescription Drug Product Claims in Direct-to-Consumer and Healthcare Provider Promotion
- Notices & guidance2022-03-24Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites
- Notices & guidance2022-03-24Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites
2021 8
- Notices & guidance2021-09-13Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials
- Notices & guidance2021-07-23Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prescription Drug Advertising
- Notices & guidance2021-07-23Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prescription Drug Advertising
- Notices & guidance2021-07-14Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Medical Conference Attendees' Observations About Prescription Drug Promotion
- Notices & guidance2021-06-11Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites
- Notices & guidance2021-06-11Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Study of Disclosures to Healthcare Providers Regarding Data That Do Not Support Unapproved Use of an Approved Prescription Drug
- Notices & guidance2021-04-29Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Prescription Drug Advertising
- Notices & guidance2021-04-29Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Prescription Drug Advertising
2020 5
- Notices & guidance2020-12-07Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Endorser Status and Explicitness of Payment in Direct-to-Consumer Promotion
- Notices & guidance2020-09-18Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Assessment of Terms and Phrases Commonly Used in Prescription Drug Promotion
- Notices & guidance2020-07-07Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Secondary Claim Disclosures and Biosimilar Disclosures in Prescription Drug Promotional Materials
- Notices & guidance2020-02-04Federal Register（Notice）Promotional Labeling and Advertising Considerations for Prescription Biological Reference and Biosimilar Products-Questions and Answers; Draft Guidance for Industry; Availability
- Notices & guidance2020-01-29Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Study of Oncology Indications in Direct-to-Consumer Television Advertising
2019 4
- Notices & guidance2019-08-19Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Dear Health Care Provider Letters: Improving Communication of Important Safety Information
- Notices & guidance2019-06-24Federal Register（Notice）Providing Regulatory Submissions in Electronic and Non-Electronic Format-Promotional Labeling and Advertising Materials for Human Prescription Drugs; Guidance for Industry; Availability
- Notices & guidance2019-06-21Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Study of Oncology Indications in Direct-to-Consumer Television Advertising
- Notices & guidance2019-04-04Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Providing Regulatory Submissions in Electronic and Non-Electronic Format-Promotional Labeling and Advertising Materials for Human Prescription Drugs
2018 7
- Notices & guidance2018-11-14Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Disclosures of Descriptive Presentations in Professional Oncology Prescription Drug Promotion
- Notices & guidance2018-10-17Federal Register（Notice）Presenting Quantitative Efficacy and Risk Information in Direct-to-Consumer Promotional Labeling and Advertisements; Draft Guidance for Industry; Availability
- Notices & guidance2018-08-14Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Experimental Study of Risk Information Amount and Location in Direct-to-Consumer Print Ads
- Notices & guidance2018-08-09Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Disclosures in Professional and Consumer Prescription Drug Promotion
- Notices & guidance2018-08-09Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Disclosures in Professional and Consumer Prescription Drug Promotion
- Notices & guidance2018-03-15Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Health Care Professional Survey of Professional Prescription Drug Promotion
- Notices & guidance2018-03-13Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Utilization of Adequate Provision Among Low to Non-Internet Users
2017 7
- Notices & guidance2017-12-12Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Consumer and Healthcare Professional Identification of and Responses to Deceptive Prescription Drug Promotion
- Notices & guidance2017-12-12Federal Register（Notice）Product Name Placement, Size, and Prominence in Promotional Labeling and Advertisements; Guidance for Industry; Availability
- Notices & guidance2017-08-21Federal Register（Notice）Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer Broadcast Advertisements; Establishment of a Public Docket; Request for Information and Comments
- Notices & guidance2017-08-21Federal Register（Notice）Content of Risk Information in the Major Statement in Prescription Drug Direct-to-Consumer Broadcast Advertisements; Establishment of a Public Docket; Request for Information and Comments
- Notices & guidance2017-08-07Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prescription Drug Advertisements
- Notices & guidance2017-06-19Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Risk Information Amount and Location in Direct-to-Consumer Print Ads
- Notices & guidance2017-05-23Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Prescription Drug Advertisements
2016 7
- Notices & guidance2016-11-29Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Superimposed Text in Direct-to-Consumer Promotion of Prescription Drugs
- Notices & guidance2016-10-25Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Animation in Direct-to-Consumer Advertising
- Notices & guidance2016-08-04Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; National Direct-to-Consumer Advertising Survey
- Notices & guidance2016-03-18Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Quantitative Information in Direct-to-Consumer Television Advertisements
- Notices & guidance2016-03-09Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Superimposed Text in Direct-to-Consumer Promotion of Prescription Drugs
- Notices & guidance2016-03-02Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Animation in Direct-to-Consumer Advertising
- Notices & guidance2016-02-29Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; National Direct-to-Consumer Advertising Survey
2015 16
- Notices & guidance2015-12-10Psychiatric NewsAMA Calls for Ban On Advertising Directed at Consumers
- Notices & guidance2015-10-30Federal Register（Notice）Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Impact of Ad Exposure Frequency on Perception and Mental Processing of Risks and Benefit Information in Direct-to-Consumer Prescription Drug Ads
- Notices & guidance2015-08-25International Journal of Health Policy and ManagementTrouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters
- Notices & guidance2015-08-19New England Journal of MedicineThe Vernacular of Risk — Rethinking Direct-to-Consumer Advertising of Pharmaceuticals
- Notices & guidance2015-08-06Federal Register（Notice）Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs; Revised Draft Guidance for Industry (Revision 2); Availability
- Notices & guidance2015-08-06Federal Register（Notice）Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Prescription Drugs; Revised Draft Guidance for Industry (Revision 2); Availability
- Notices & guidance2015-07-20Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Market Claims in Direct-to-Consumer Prescription Drug Print Ads
- Notices & guidance2015-06-17Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Impact of Ad Exposure Frequency on Perception and Mental Processing of Risk and Benefit Information in Direct-to-Consumer Prescription Drug Ads
- Notices & guidance2015-06-10Federal Register（Notice）Agency Information Collection Activities; Announcement of Office of Management and Budget Approval Comparative Price Information in Direct-to-Consumer and Professional Prescription Drug Advertisements
- Notices & guidance2015-06-03Federal Register（Notice）Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements
- Notices & guidance2015-05-26Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Spousal Influence on Consumer Understanding of and Response to Direct-to-Consumer Prescription Drug Advertisements
- Notices & guidance2015-04-22Federal Register（Notice）Providing Regulatory Submissions in Electronic and Non-Electronic Format-Promotional Labeling and Advertising Materials for Human Prescription Drugs, Draft Guidance for Industry; Availability
- Notices & guidance2015-04-06Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Comparative Price Information in Direct-to-Consumer and Professional Prescription Drug Advertisements
- Notices & guidance2015-02-09Federal Register（Notice）Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Human Prescription Drugs; Revised Draft Guidance for Industry; Availability
- Notices & guidance2015-02-09Federal Register（Notice）Brief Summary and Adequate Directions for Use: Disclosing Risk Information in Consumer-Directed Print Advertisements and Promotional Labeling for Human Prescription Drugs; Revised Draft Guidance for Industry; Availability
- Notices & guidance2015-01-13Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements
2014 12
- Notices & guidance2014-11-14Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Spousal Influence on Consumer Understanding of and Response to Direct-To-Consumer Prescription Drug Advertisements
- Notices & guidance2014-11-12Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Impact of Ad Exposure Frequency on Perception and Mental Processing of Risk and Benefit Information in Direct-to-Consumer Prescription Drug Ads
- Notices & guidance2014-09-12Federal Register（Notice）Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Eye Tracking Study of Direct-to-Consumer Prescription Drug Advertisement Viewing
- Notices & guidance2014-07-21Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Experimental Study of Direct-to-Consumer Promotion Directed at Adolescents
- Notices & guidance2014-06-18Federal Register（Notice）Draft Guidance for Industry on Internet/Social Media Platforms With Character Space Limitations: Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices; Availability
- Notices & guidance2014-06-05Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prescription Drug Advertisements
- Notices & guidance2014-05-07Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Comparative Price Information in Direct-to-Consumer and Professional Prescription Drug Advertisements
- Notices & guidance2014-05-07Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Comparative Price Information in Direct-to-Consumer and Professional Prescription Drug Advertisements
- Notices & guidance2014-03-03Federal Register（Notice）Revised Draft Guidance for Industry on Distributing Scientific and Medical Publications on Unapproved New Uses-Recommended Practices; Availability
- Notices & guidance2014-02-27Federal Register（Notice）Agency Information Collection Activities: Proposed Collection; Comment Request; Prescription Drug Advertisements
- Notices & guidance2014-02-18Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Disclosure Regarding Additional Risks in Direct-to-Consumer Prescription Drug Television Advertisements
- Notices & guidance2014-01-23Federal Register（Notice）Guidance for Industry and Food and Drug Administration Staff on Dear Health Care Provider Letters: Improving Communication of Important Safety Information; Availability
2013 5
- Notices & guidance2013-11-29Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Eye Tracking Study of Direct-to-Consumer Prescription Drug Advertisement Viewing
- Notices & guidance2013-11-20Federal Register（Notice）Draft Guidance for Industry on Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling; Availability
- Notices & guidance2013-11-20Federal Register（Notice）Draft Guidance for Industry on Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling; Availability
- Notices & guidance2013-10-31Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Direct-to-Consumer Promotion Directed at Adolescents
- Notices & guidance2013-05-14Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Communicating Composite Scores in Direct-to-Consumer Advertising
2012 9
- Notices & guidance2012-12-26Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Experimental Study: Examination of Corrective Direct-to-Consumer Television Advertising
- Notices & guidance2012-10-11Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Healthcare Professional Survey of Prescription Drug Promotion
- Notices & guidance2012-08-23Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Communicating Composite Scores in Direct-to-Consumer Advertising
- Notices & guidance2012-07-19Federal Register（Notice）Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Examination of Online Direct-to-Consumer Prescription Drug Promotion
- Notices & guidance2012-06-27Federal Register（Notice）Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Experimental Study: Effect of Promotional Offers in Direct-to-Consumer Prescription Drug Print Advertisements on Consumer Product Perceptions
- Notices & guidance2012-03-13Federal Register（Notice）Draft Guidance for Industry on Direct-to-Consumer Television Advertisements-the Food and Drug Administration Amendments Act of 2007 Direct-to-Consumer Television Ad Pre-Dissemination Review Program; Availability
- Notices & guidance2012-01-25Federal Register（Notice）Guidance for Industry on Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling; Availability
- Notices & guidance2012-01-17Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Healthcare Professional Survey of Prescription Drug Promotion
- Notices & guidance2012-01-17Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Healthcare Professional Survey of Prescription Drug Promotion
2011 9
- Notices & guidance2011-12-30Federal Register（Notice）Draft Guidance for Industry on Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices; Availability
- Notices & guidance2011-12-28Federal Register（Notice）Communications and Activities Related to Off-Label Uses of Marketed Products and Use of Products Not Yet Legally Marketed; Request for Information and Comments
- Notices & guidance2011-12-19Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Online Direct-to-Consumer Prescription Drug Promotion
- Notices & guidance2011-12-19Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Examination of Online Direct-to-Consumer Prescription Drug Promotion
- Notices & guidance2011-09-19Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Experimental Study: Effect of Promotional Offers in Direct-to-Consumer Prescription Drug Print Advertisements on Consumer Product Perceptions
- Notices & guidance2011-07-01Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Comparative Direct-to-Consumer Advertising
- Notices & guidance2011-07-01Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Experimental Study of Format Variations in the Brief Summary of Direct-to-Consumer Print Advertisements
- Notices & guidance2011-04-28Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Online Direct-to-Consumer Prescription Drug Promotion
- Notices & guidance2011-01-24Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Prescription Drug Advertisements
2010 4
- Notices & guidance2010-09-22Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study: Effect of Promotional Offers in Direct-to-Consumer Prescription Drug Print Advertisements on Consumer Product Perceptions
- Notices & guidance2010-08-31Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Format Variations in the Brief Summary of Direct-to-Consumer Print Advertisements
- Notices & guidance2010-06-16Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Study of Clinical Efficacy Information in Professional Labeling and Direct-to-Consumer Print Advertisements for Prescription Drugs
- Notices & guidance2010-03-17Federal Register（Notice）Agency Information Collection Activities: Proposed Collection; Comment Request; Prescription Drug Advertisements
2009 2
- Notices & guidance2009-06-22Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Presentation of Quantitative Effectiveness Information to Consumers in Direct-to-Consumer Television and Print Advertisements for Prescription Drugs
- Notices & guidance2009-05-27Federal Register（Notice）Draft Guidance for Industry on Presenting Risk Information in Prescription Drug and Medical Device Promotion; Availability
2008 5
- Notices & guidance2008-12-30Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct-to-Consumer Prescription Drug Broadcast Advertisements
- Notices & guidance2008-11-26Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study: Toll-Free Number for Consumer Reporting of Drug Product Side Effects in Direct-to-Consumer Television Advertisements for Prescription Drugs
- Notices & guidance2008-08-06Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct-to-Consumer Prescription Drug Broadcast Advertisements
- Notices & guidance2008-04-22JAMAFDA Guidance on Off-Label Promotion and the State of the Literature From Sponsors
- Notices & guidance2008-01-16Federal Register（Notice）User Fee Program for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products; Program Will Not Be Implemented
2007 7
- Notices & guidance2007-12-11Federal Register（Notice）Establishment of Fiscal Year 2008 User Fee Rates for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products
- Notices & guidance2007-10-25Federal Register（Notice）User Fee Program for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products; Request for Notification of Participation and Number of Advertisements for Review
- Notices & guidance2007-10-25Federal Register（Notice）User Fee Program for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products; Request for Notification of Participation and Number of Advertisements for Review
- Notices & guidance2007-10-22Federal Register（Notice）Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Experimental Evaluation of Variations in Content and Format of the Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs
- Notices & guidance2007-08-22Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct-to-Consumer Prescription Drug Broadcast Advertisements
- Notices & guidance2007-08-22Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of the Impact of Distraction on Consumer Understanding of Risk and Benefit Information in Direct-to-Consumer Prescription Drug Broadcast Advertisements
- Notices & guidance2007-03-14Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Experimental Evaluation of Variations in Content and Format of the Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs
2006 4
- Notices & guidance2006-06-09Federal Register（Notice）Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs: Study 1
- Notices & guidance2006-04-25Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of Variations in Content and Format of the Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs
- Notices & guidance2006-04-25Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of Variations in Content and Format of the Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs
- Notices & guidance2006-02-06Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Impact of Coupons on Consumer Perceptions of Products in Prescription Drugs in Direct-to-Consumer Prescription Drug Print Advertisements
2005 5
- Notices & guidance2005-12-20JNCI Journal of the National Cancer InstituteFDA Considers Tightening Regulations for Direct-to-Consumer Advertising
- Notices & guidance2005-12-15Federal Register（Notice）Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs: Study 1
- Notices & guidance2005-09-13Federal Register（Notice）Consumer-Directed Promotion of Regulated Medical Products; Public Hearing
- Notices & guidance2005-02-08Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs: Study 1
- Notices & guidance2005-02-08Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Evaluation of Consumer-Friendly Formats for Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs: Study 1
2004 1
- Notices & guidance2004-02-10Federal Register（Notice）Draft Guidances for Industry on Improving Information About Medical Products and Health Conditions; Withdrawal; Availability
2002 1
- Notices & guidance2002-02-08Federal Register（Notice）Agency Information Collection Activities; Announcement of OMB Approval; Assessment of Physician and Patient Attitudes Toward Direct-to-Consumer Promotion of Prescription Drugs
2001 11
- Notices & guidance2001-10-22Federal Register（Notice）Agency Information Collection Activities; Announcement of OMB Approval; Transmittal of Advertising and Promotional Labeling for Drugs and Biologics for Human Use
- Notices & guidance2001-08-14Federal Register（Notice）Agency Information Collection Activities; Submission for OMB Review; Comment Request; Assessment of Physician and Patient Attitudes Toward Direct-to-Consumer (DTC) Promotion Drugs; Survey
- Notices & guidance2001-06-01Federal Register（Notice）Agency Information Collection Activities; Proposed Collections; Reopening of Comment Period; Direct-to-Consumer Promotion of Prescription Drugs
- Notices & guidance2001-06-01Federal Register（Notice）Agency Information Collection Activities; Proposed Collections; Reopening of Comment Period; Direct-to-Consumer Promotion of Prescription Drugs
- Notices & guidance2001-05-08Federal Register（Notice）Agency Information Collection Activities; Submission for OMB Review; Comment Request; Transmittal of Advertising and Promotional Labeling for Drugs and Biologics for Human Use
- Notices & guidance2001-05-08Federal Register（Notice）Agency Information Collection Activities; Submission for OMB Review; Comment Request; Transmittal of Advertising and Promotional Labeling for Drugs and Biologics for Human Use
- Notices & guidance2001-04-23Federal Register（Notice）Draft Guidance for Industry on Using FDA-Approved Patient Labeling in Consumer-Directed Print Advertisements; Availability
- Notices & guidance2001-03-19Federal Register（Notice）Agency Information Collection Activities; Proposed Collections; Comment Request; Assessment of Physician and Patient Attitudes Toward Direct-to-Consumer Promotion of Prescription Drugs
- Notices & guidance2001-03-19Federal Register（Notice）Agency Information Collection Activities; Proposed Collections; Comment Request; Assessment of Physician and Patient Attitudes Toward Direct-to-Consumer Promotion of Prescription Drugs
- Notices & guidance2001-01-31Federal Register（Notice）Draft Guidance for Industry on Providing Regulatory Submissions in Electronic Format, Prescription Drug Advertising and Promotional Labeling; Availability
- Notices & guidance2001-01-31Federal Register（Notice）Draft Guidance for Industry on Providing Regulatory Submissions in Electronic Format, Prescription Drug Advertising and Promotional Labeling; Availability
2000 2
- Notices & guidance2000-12-21Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Transmittal of Advertising and Promotional Labeling for Drugs and Biologics for Human Use
- Notices & guidance2000-12-21Federal Register（Notice）Agency Information Collection Activities; Proposed Collection; Comment Request; Transmittal of Advertising and Promotional Labeling for Drugs and Biologics for Human Use
1999 4
- Notices & guidance1999-08-09Federal Register（Notice）Guidance For Industry on Consumer-Directed Broadcast Advertisements; Availability
- Notices & guidance1999-03-26Federal Register（Notice）Draft Guidance for Industry on Accelerated Approval Products: Submission of Promotional Materials; Availability
- Notices & guidance1999-03-12Federal Register（Notice）Draft Guidance for Industry on Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling; Availability
- Notices & guidance1999-03-12Federal Register（Notice）Draft Guidance for Industry on Product Name Placement, Size, and Prominence in Advertising and Promotional Labeling; Availability
1998 4
- Notices & guidance1998-09-16Federal Register（Notice）Agency Emergency Processing Request Under OMB Review; Attitudinal and Behavorial Efffects of Direct-To-Consumer Advertising of Prescription Drugs
- Notices & guidance1998-09-16Federal Register（Notice）Agency Emergency Processing Request Under OMB Review; Attitudinal and Behavorial Efffects of Direct-To-Consumer Advertising of Prescription Drugs
- Notices & guidance1998-08-28Federal Register（Notice）Agency Information Collection Activities; Announcement of OMB Approval; Transmittal of Advertisements and Promotional Labeling for Drugs and Biologics for Human Use
- Notices & guidance1998-01-05Federal Register（Notice）Draft Guidance for Industry: ``Promoting Medical Products in a Changing Healthcare Environment; I. Medical Product Promotion by Healthcare Organizations or Pharmacy Benefits Management Companies (PBMs)''
1997 1
- Notices & guidance1997-08-12Federal Register（Notice）Draft Guidance for Industry; Consumer-Directed Broadcast Advertisements; Availability
1995 1
- Notices & guidance1995-10-05Federal Register（Notice）Professional Product Labeling; Public Meeting
1991 1
- Notices & guidance1991-07-01PEDIATRICSPrescription Drug Advertising Direct to the Consumer